What You Should Know:
– Manifold, an AI-powered clinical research platform raises $15M in a Series A funding round led by TQ Ventures with participation from Calibrate Ventures, SK Ventures, and existing investors TTCER Partners and Dr. Sachin H. Jain.
– By accelerating research progress, Manifold paves the way for faster development of life-saving treatments and improved patient outcomes.
AI-Powered Clinical Research Platform
Manifold tackles a critical challenge in medical research: slow and inefficient workflows. Legacy data management systems hinder research progress, delaying breakthroughs that could improve patient outcomes. Manifold’s AI platform tackles this issue head-on by:
- Streamlining Workflows: Automating manual tasks associated with study management and data collection frees up researchers’ time for high-impact work.
- Rapid Insights Generation: Manifold reduces the time needed to extract valuable insights from research data, accelerating the pace of discovery.
- Unified Data Management: The platform integrates complex patient data sets, creating a comprehensive view for researchers.
- Enhanced Collaboration: Secure, multi-institutional collaboration features empower researchers to work together seamlessly.
Client & Outcomes
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute of Emory University are among the institutions leveraging Manifold’s platform. One research organization successfully unified a massive 11 terabytes of patient data from 1.5 million individuals onto a single platform. This not only streamlined operations but also unlocked new possibilities for large-scale collaborative research.
“Manifold is transforming clinical research by providing research organizations with purpose-built technology infrastructure for this new era,” said Vinay Seth Mohta, CEO and Co-Founder of Manifold. “Our vision is to make it ten times faster and one-tenth the cost to conduct modern research studies that unlock insights never-before possible.”
